No Data
No Data
Aptinyx To Go Ex-Dividend On January 2nd, 2024 With 0.09869 USD Dividend Per Share
December 27th - $Aptinyx(APTX.US)$ is trading ex-dividend on January 2nd, 2024. Shareholders of record on December 26th, 2023 will receive 0.09869 USD dividend per share on December 29th, 2023. Th
Parkinson's Disease Psychosis Market Is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight | Key Companies Working to Develop Therapies - Vanda, Kyowa Kirin, Sage, Athira, Aptinyx, CogState, AgeneBio
The dynamics of the Parkinson's disease psychosis market are anticipated to change in the coming years owing to the improvement in diagnosis methodologies, rising awareness of the disease, incrementa
Aptinyx Inc. (APTX) Witnesses Remarkable Recovery Amidst Challenges
Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company specializing in brain and nervous system disorder treatments, is experiencing an astonishing after-market price surge. Despite a challenging day, the stock is making an epic recovery, soaring by an impressive 21% after hours. This unexpected jump is capturing attention and raising speculation about the factors driving Aptinyx ...
Short Interest in Aptinyx Inc. (NASDAQ:APTX) Decreases By 11.6%
Aptinyx Inc. (NASDAQ:APTX – Get Rating) saw a significant decrease in short interest in April. As of April 15th, there was short interest totalling 2,890,000 shares, a decrease of 11.6% from the Marc
Aptinyx Inc. (NASDAQ:APTX) Expected to Post Q1 2024 Earnings of ($0.06) Per Share
Aptinyx Inc. (NASDAQ:APTX – Get Rating) – William Blair issued their Q1 2024 EPS estimates for Aptinyx in a research note issued on Friday, March 31st. William Blair analyst M. Minter forecasts tha
Stocks That Hit 52-Week Lows On Friday
 On Friday, 93 stocks made new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Canopy Gwth (NASDAQ:CGC) was the largest, in terms of market cap, to set a new 52-week low.Biodexa Pharmace
No Data